Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate Safety and Therapeutic Efficacy of a Combination Therapy of 'Oncoxin', a Nutritional Supplement and Surafenib, a Multikinase Inhibitor in Patients With Hepatocellular Carcinoma

NCT01747642 is registered in ClinicalTrials.gov with Clinical Research Organization, Dhaka, Bangladesh as lead sponsor.

NCT NCT01747642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01747642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate Safety and Therapeutic Efficacy of a Combination Therapy of 'Oncoxin', a Nutritional Supplement and Surafenib, a Multikinase Inhibitor in Patients With Hepatocellular Carcinoma
Lead sponsor
Clinical Research Organization, Dhaka, Bangladesh
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 31, 2012
Completion date
June 30, 2014
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

quality of life